Short answer: for secondary hypogonadism, enclomiphene preserves sperm production while raising testosterone; standard TRT typically suppresses it. Enclomiphene won't work for primary (testicular) hypogonadism — TRT does.
If fertility is a factor in your decision about low testosterone treatment, the choice between standard TRT and enclomiphene isn't just a preference — it comes down to two genuinely opposite mechanisms with very different consequences for sperm production. Here's a direct comparison.
Opposite Mechanisms, Opposite Outcomes
Standard testosterone therapy supplies testosterone directly from outside the body. The hypothalamus and pituitary sense that supply and respond by suppressing GnRH, LH, and FSH release through negative feedback. Enclomiphene works the other way — it blocks estrogen receptors in the hypothalamus, which increases GnRH pulses and raises LH and FSH, stimulating the testes to produce more testosterone on their own.[1]Because TRT bypasses the testes entirely, it doesn't preserve the LH/FSH signaling that drives sperm production — while enclomiphene's entire mechanism depends on that exact signaling pathway staying active.[2]
What the Trial Data Shows
The clearest head-to-head evidence comes from parallel Phase 3 randomized trials comparing enclomiphene to topical testosterone gel in 256 men with secondary hypogonadism. Enclomiphene maintained sperm concentrations in the normal range, while testosterone gel caused a significant, marked drop.[1] FSH and LH rose in the enclomiphene group and fell in the testosterone group — and using a combined measure of normal testosterone plus adequate sperm concentration, treatment success was achieved in 63.5% of men on enclomiphene versus just 24.7% on testosterone gel.[1] A separate study of 12 men who switched from six-plus months of topical testosterone to enclomiphene found sperm counts rose to a mean of 176 million/mL after switching — significantly higher than while those same men were on testosterone.[1]A broader review confirms this isn't a one-off finding: multiple studies have shown enclomiphene outperforms testosterone at preserving semen parameters in men with secondary hypogonadism.[3]
The Candidacy Question That Matters Most
Before either option makes sense, there's a diagnostic distinction that determines whether enclomiphene can even work: primary versus secondary hypogonadism.
- Secondary hypogonadism(a hypothalamic-pituitary signaling problem, with testes still capable of responding) — this is the only population enclomiphene's mechanism can work in, since it depends entirely on stimulating testes that are still functional.[4]
- Primary hypogonadism(testicular failure) — the testes can't respond to increased LH/FSH signaling no matter how much enclomiphene raises it, which makes TRT the only viable hormonal option in this group.[5]
TRT is FDA-approved and effective for both types of hypogonadism, since it supplies testosterone directly rather than relying on any remaining testicular responsiveness.[5]
Regulatory note:Neither drug carries an FDA-approved indication specifically for fertility preservation. Enclomiphene has never received FDA approval for any use, and its parent compound clomiphene is approved only for female ovulation induction. FDA-approved testosterone products are approved for confirmed hypogonadism, but explicitly not studied or labeled for fertility preservation — TRT's documented effect runs the opposite direction.[5]
How to Think About the Choice
A peer-reviewed comparative review sums up enclomiphene's role plainly: it functions as a treatment that maintains fertility in men with secondary hypogonadism, with clinicians weighing it against the closely related clomiphene mainly based on differing estrogenic side-effect profiles.[4] Practically, that puts men into two groups:
- Men actively trying to conceive (or planning to soon) with confirmed secondary hypogonadism are the clearest candidates for enclomiphene — the trial data specifically shows it maintains sperm production while still raising testosterone.[1]
- Men not currently concerned with fertility, or those with primary hypogonadism where enclomiphene's mechanism simply can't work, are better suited to standard FDA-approved TRT.[5]
The Bottom Line
This isn't a close call once fertility and hypogonadism type are both accounted for. If you have secondary hypogonadism and fertility matters now or in the near future, enclomiphene has real trial evidence behind it as the fertility-preserving option. If you have primary hypogonadism, or fertility isn't a current concern, standard TRT remains the FDA-approved, well-established choice. The diagnostic step — confirming which type of hypogonadism you actually have — is the part worth getting right before choosing between them.
Not every Men's Health provider offers enclomiphene as an option — compare options on RENVA's Men's Health / TRT hub if fertility preservation is a priority for you.
Sources
- Enclomiphene Citrate for the Treatment of Secondary Male Hypogonadism — PMC (National Institutes of Health) pmc.ncbi.nlm.nih.gov
- Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies — Translational Andrology and Urology (AME Publishing) tau.amegroups.org
- Preserving fertility in the hypogonadal patient: an update — PMC (National Institutes of Health) pmc.ncbi.nlm.nih.gov
- Safety and efficacy of enclomiphene and clomiphene for the treatment of hypogonadism — PMC (National Institutes of Health) pmc.ncbi.nlm.nih.gov
- Testosterone Information — U.S. Food and Drug Administration fda.gov
Frequently Asked Questions
Can enclomiphene work for anyone with low testosterone?
No — it only works for secondary hypogonadism, where the testes are still capable of responding to increased hormone signaling. It won't work for primary (testicular) hypogonadism.[4]
How much better is enclomiphene than TRT for fertility?
In a large randomized trial, 63.5% of men on enclomiphene hit a combined testosterone-and-fertility success measure, compared to 24.7% on testosterone gel.[1]
Is enclomiphene FDA-approved for fertility preservation?
No. Enclomiphene has never received FDA approval for any indication — its use for fertility preservation is off-label.[5]
If I have primary hypogonadism, can I still use enclomiphene?
No — enclomiphene's mechanism requires functioning testes capable of responding to increased signaling. In primary hypogonadism the testes have already failed, making TRT the only viable hormonal option.[5]